Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BCAS2 pseudogene 3 (BCAS2P3) is a non-functional genomic element derived from the BCAS2 gene, which encodes a pre-mRNA processing factor involved in mRNA splicing and the DNA damage response[2][3]. BCAS2P3 does not produce a functional protein product. Pseudogenes like BCAS2P3 are generally considered genomic relics of protein-coding genes and may occasionally have regulatory roles (such as acting as competing endogenous RNAs, or ceRNAs, modulating gene expression), but for BCAS2P3 there are no published biological functions, disease associations, or validation as a target for drug development[6]. Therefore, it is not accurate to consider BCAS2P3 a therapeutic target.
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCAS2 pseudogene 3 (BCAS2P3).